XB-FEAT-6076061: Difference between revisions
imported>Xenbase gene generator No edit summary |
imported>Xenbase (→bcar3) |
||
| Line 1: | Line 1: | ||
=bcar3= | =bcar3= | ||
This is the community wiki page for the gene ''bcar3'' please feel free to add any information that is relevant to this gene that is not already captured elsewhere in Xenbase | This is the community wiki page for the gene ''bcar3'' please feel free to add any information that is relevant to this gene that is not already captured elsewhere in Xenbase. | ||
=nomenclature changes= | |||
10/24/2017 | |||
Human name has changed for Entrez Gene: 8412. From breast cancer anti-estrogen resistance 3 to | |||
BCAR3, NSP family adaptor protein | |||
=NCBI summary= | |||
Also known as | |||
NSP2; AND-34; SH2D3B | |||
Breast tumors are initially dependent on estrogens for growth and progression and can be inhibited by anti-estrogens such as tamoxifen. However, breast cancers progress to become anti-estrogen resistant. Breast cancer anti-estrogen resistance gene 3 was identified in the search for genes involved in the development of estrogen resistance. The gene encodes a component of intracellular signal transduction that causes estrogen-independent proliferation in human breast cancer cells. The protein contains a putative src homology 2 (SH2) domain, a hall mark of cellular tyrosine kinase signaling molecules, and is partly homologous to the cell division cycle protein CDC48. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012] | |||
Latest revision as of 06:43, 24 October 2017
bcar3
This is the community wiki page for the gene bcar3 please feel free to add any information that is relevant to this gene that is not already captured elsewhere in Xenbase.
nomenclature changes
10/24/2017 Human name has changed for Entrez Gene: 8412. From breast cancer anti-estrogen resistance 3 to BCAR3, NSP family adaptor protein
NCBI summary
Also known as NSP2; AND-34; SH2D3B
Breast tumors are initially dependent on estrogens for growth and progression and can be inhibited by anti-estrogens such as tamoxifen. However, breast cancers progress to become anti-estrogen resistant. Breast cancer anti-estrogen resistance gene 3 was identified in the search for genes involved in the development of estrogen resistance. The gene encodes a component of intracellular signal transduction that causes estrogen-independent proliferation in human breast cancer cells. The protein contains a putative src homology 2 (SH2) domain, a hall mark of cellular tyrosine kinase signaling molecules, and is partly homologous to the cell division cycle protein CDC48. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]